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0307: BENEFIT OF PERCUTANEOUS NEPHROSTOMY IN MALIGNANT
URETERIC OBSTRUCTION
A. Downey*, S. Venugopal, M. Philips, S. Kennish, F. Salim, J. Patterson.
Royal Hallamshire Hospital, Shefﬁeld, UK.
Introduction: Percutaneous nephrostomy (PCN) for malignant ureteric
obstruction is an effective method of urinary diversion. There are no
guidelines/selection criteria to guide decision-making; particularly in
recurrent/advanced disease. Watkinson et.al. stratiﬁed patients into 4
groups. We aimed to identify survival beneﬁt and morbidity following PCN
for malignant obstruction.
Methods:We identiﬁed 86 patients stratiﬁed them as per Watkinson et.al.
- Group I:non-malignant complication from previous surgery/radio-
therapy (14 patients), II:untreated primary (20), III:relapsed disease viable
treatment option (28) and IV:relapsed disease no treatment option (24).
Most common primary tumour was bladder(34%). 43% were elective, 57%
emergency (sepsis 34%, AKI/Hyperkalaemia 57%).
Results: Median survival post-PCN was 35.5 days in Group IV versus 212
and 207.5 days in Groups II and III. 1-year survival was 0 in Group IV, 20% in
II and 16% in III. 76% group IV patients had nephrostomies in-situ at death
(6% Group I, 10% Group II, 50% Group III). 26 patients required readmission
for complications.
Conclusions: Patients with relapsed malignancy and no conventional
treatment option have a shorter survival than Groups I-III. Additionally,
30% of all patients are readmitted with related complications. The decision
for PCN should be based on prognosis and available treatment options
whilst considering individual patient's comorbidities and wishes.http://dx.doi.org/10.1016/j.ijsu.2016.08.057
0209: GENOMIC AND PROGNOSTIC ASSOCIATIONS OF E-CADHERIN IN
BREAST CANCER: AN IMMUNOHISTOCHEMICAL STUDY OF 3273 PA-
TIENTS, SYSTEMATIC REVIEW AND META-ANALYSIS
S. Rossi*, R. Ali, P. Pharoah. Department of Public Health at the University of
Cambridge, Cambridge, UK.
Few sufﬁciently powered studies have been published on the signiﬁcance
of E-cadherin in breast cancer survival, generating conﬂicting evidence.
The relevance of loss of CDH1 relative to genomic subtypes of breast cancer
has not been systematically investigated. We assessed CDH1 alterations
and protein expression relative to IntClust subtypes in 732 patients from
The Cancer Genome Atlas. E-cadherin protein expression was signiﬁcantly
lower in patients with CDH1 mutations compared to wild type
(p < 0.0001). Prevalence of mutations were more common in IntClust 3
(8.4%), and IntClust 8 (11.4%), compared to other subtypes (p < 0.0001).
Furthermore, we performed a systematic review and meta-analysis of
1299 articles from the PubMed database. We included 36 published
studies, with data on 9070 patients, as well as unpublished patient-level
data from an additional 3272 patients from the SEARCH and NEAT studies.
Reduced E-cadherin expression was signiﬁcantly associated with
increased all-cause mortality (HR 1.22, 95% CI 1.04 e 1.44; p ¼ 0.02) and
breast cancer speciﬁc mortality (HR 1.18, 95% CI 1.02 e 1.35; p ¼ 0.02).
E-cadherin expression is strongly inﬂuenced by mutation and modestly
inﬂuenced by methylation, with little contribution from copy number al-
terations. We demonstrate that reduced E-cadherin expression is a sig-
niﬁcant predictor of poor survival, albeit with a relatively small effect size.http://dx.doi.org/10.1016/j.ijsu.2016.08.0581165: IMPACT OF EARLY POSTOPERATIVE COMPLICATIONS ON DISEASE
FREE SURVIVAL AFTER MAJOR RESECTION OF COLORECTAL CANCER
O. Ali a,*, F. Awad a, K. Gill a, A. Bhangu b. aDepartment of colorectal surgery,
Sandwell and West Birmingham NHS Trust, UK; bAcademic Department of
Surgery, University of Birmingham, Birmingham, UK.
Background: Impact of early postoperative morbidity from colorectal
cancer surgery is unknown. This study aimed to determine whether pre-
speciﬁed complications impacted disease free survival after resection of
colorectal cancer.
Methods: Patients undergoing surgery with curative intent for colorectal
cancer over 2 years were included. Pre-deﬁned complications recorded
were anastomotic leak, hospital acquired pneumonia(HAP), surgical site
infection(SSI) and ileus. Primary endpoint was 3-year disease free survi-
val(DFS). Cox’s proportional models generated hazard ratios(HR),
excluding patients who died within 30 days of surgery.
Results: Of 220 patients, 55% underwent surgery for a colonic cancer.
The 30-day mortality rate was 0.9%(n ¼ 2) and positive resection margin
rate 5.9% (3.3% colon, 9.1% rectum). The overall complication rate was
56.3%. Speciﬁc complication rates were 11.3% anastomotic leak, 11.8%
HAP, 15.0% SSI and 13.2% ileus. Including patients undergoing anasto-
mosis, leak (HR 4.7,1.5 e 15.5) predicted reduced DFS similar to a posi-
tive resection margin (HR 3.7,1.1 e 14.8). In models containing all
patients, HAP predicted reduced survival (HR 8.0,3.1 e 20.9) similar level
to a positive resection margin (HR 8.0,3.1 e 20.9). SSI and ileus were not
signiﬁcant.
Conclusion: HAP and anastomotic leak decrease disease free survival to a
level comparable to that of a positive resection margin. Further strategies
ought to target reduction in perioperative complications.http://dx.doi.org/10.1016/j.ijsu.2016.08.059
0434: IMPACT OF LYMPHOEDEMA ON QUALITY OF LIFE FOLLOWING
RADICAL LYMPH NODE DISSECTION FOR PENILE CANCER
E. White*, J. Minter, A. Coscione, W. Lam, D. Sharma, T. Yap, N. Watkin,
B. Ayres. St George's Hospitals NHS Foundation Trust, London, UK.
Aim: Inguinal and pelvic lymphadenectomy in penile cancer can result in
signiﬁcant lymphoedema. The aim of this study was to assess the impact of
any lower limb and/or genital lymphoedema on quality of life using a
validated questionnaire.
Method: Between June and December 2015, 26 patients who attended
clinic for surveillance following their lymph node surgery were asked to
complete the validated LYMQOL LEG questionnaire. 16 had both inguinal
and pelvic lymph node dissections. 12 had adjuvant inguinal +/- pelvic
chemoradiotherapy.
Results: Median patient age was 62 years (range 47 e 82). Median time
since nodal surgery was 25 months (2 e 90). Functional questions scored
poorer overall. Comparing inguinal lymphadenectomy only to inguinal and
pelvic lymphadenectomy, 22% men averaged a poor overall score on the
functional domain compared with 50%. For the appearance domain it was
11% vs 13%, symptoms domain 11% vs 25%, and mood domain 0% vs 38%.
Multiple logistic regression analysis showed a statistically signiﬁcant cor-
relation between symptom score and whether the patient had had adju-
vant chemoradiotherapy (p ¼ 0.015).
Conclusions: Inguinal and pelvic lymphadenectomy in penile cancer im-
pacts more on function than appearance, symptoms or mood. However,
patients generally score their overall quality of life quite high.http://dx.doi.org/10.1016/j.ijsu.2016.08.060
